Hepatocellular carcinoma without cirrhosis: Think acute hepatic porphyrias and vice versa

Journal of Internal Medicine

Volumn 269, Issue 5, 2011, Pages 521-524

  Deybach, J C ^a,b   Puy, H ^a,b  

^a HÔPITAL LOUIS MOURIER   (France)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; DIAGNOSTIC TEST; ECHOGRAPHY; EDITORIAL; FOLLOW UP; HEALTH CARE; HEMOCHROMATOSIS; HEPATIC COPROPORPHYRIA; HEPATIC PORPHYRIA; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PORPHYRIA VARIEGATA; PRIORITY JOURNAL; PROGNOSIS;

EID: 79954685084     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2011.02358.x     Document Type: Editorial

References (17)

1. Puy H, Gouya L, Deybach JC. Porphyrias. Lancet 2010; 375: 924-37.
2. Johnson PJ, Williams R. Cirrhosis and aetiology of hepatocellular carcinoma. J Hepatol 1987; 4: 140-7.
3. Kauppinen R, Mustajoki P. Acute hepatic porphyria and hepatocellular carcinoma. Br J Cancer 1988; 57: 117-20.
4. Andersson C, Bjersing L, Lithner F. The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria. J Intern Med 1996; 240: 195-201.
5. Hardell L, Bengtsson NO, Jonsson U, Eriksson S, Larsson LG. Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria - an epidemiological investigation. Br J Cancer 1984; 50: 389-97.
6. Andant C, Puy H, Faivre J, Deybach JC. Acute hepatic porphyrias and primary liver cancer. N Engl J Med 1998; 338: 1853-4.
7. Andant C, Puy H, Bogard C et al. Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. J Hepatol 2000; 32: 933-9.
8. Andant C, Puy H, Deybach JC, Soule JC, Nordmann Y. Occurrence of hepatocellular carcinoma in a case of hereditary coproporphyria. Am J Gastroenterol 1997; 92: 1389-90.
9. Schneider-Yin X, Tuyll vanSerooskerken A-M, Went P et al. Hepatocellular carcinoma in variegate porphyria: a serious complication. Acta Derm Venereol 2010; 90: 512-5.
10. Kauppinen R. Porphyrias. Lancet 2005; 365: 241-52.
11. Innala E, Andersson C. Screening for hepatocellular carcinomain acute intermittent porphyria: a 15-year follow-up in northern Sweden. J Intern Med 2011269: 538-45.
12. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 2005; 25: 143-54.
13. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986; 6: 729-38.
14. Regan LS. Screening for hepatocellular carcinoma in high risk individuals. A critical review. Arch Intern Med 1989; 149: 1741-4.
15. Bugianesi E, Leone N, Vanni E et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123: 134-40.
16. Onuki J, Teixeira PC, Medeiros MH et al. Is 5-aminolevulinic acid involved in the hepatocellular carcinogenesis of acute intermittent porphyria? Cell Mol Biol (Noisy-le-grand) 2002; 48: 17-26.
17. Dragani TA. Risk of HCC: genetic heterogeneity and complex genetics. J Hepatol 2010; 52: 252-7.